PCRX - Pacira Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PCRX is currently covered by 11 analysts with an average price target of $25.86. This is a potential upside of $9.26 (55.78%) from yesterday's end of day stock price of $16.6.

Pacira Pharmaceuticals's activity chart (see below) currently has 238 price targets and 240 ratings on display. The stock rating distribution of PCRX is 9.43% HOLD and 90.57% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 68.48% with an average time for these price targets to be met of 330.54 days.

Highest price target for PCRX is $57, Lowest price target is $10, average price target is $25.86.

Most recent stock forecast was given by BALAJI PRASAD from BARCLAYS on 12-Nov-2024. First documented stock forecast 18-Jan-2013.

Currently out of the existing stock ratings of PCRX, 5 are a HOLD (9.43%), 48 are a BUY (90.57%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$17

$0.4 (2.41%)

$25

5 days ago
(12-Nov-2024)

2/11 (18.18%)

$0.06 (0.35%)

432

Buy

$22

$5.4 (32.53%)

$22

9 days ago
(08-Nov-2024)

2/17 (11.76%)

$4.76 (27.61%)

878

Hold

$16

$-0.6 (-3.61%)

$15

10 days ago
(07-Nov-2024)

1/9 (11.11%)

$-1.9 (-10.61%)

11

Buy

$37

3 months 5 days ago
(12-Aug-2024)

22/26 (84.62%)

$16.35 (79.18%)

55

Buy

$11

$-5.6 (-33.73%)

$42

3 months 5 days ago
(12-Aug-2024)

12/22 (54.55%)

$-1.29 (-10.50%)

373

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PCRX (Pacira Pharmaceuticals) average time for price targets to be met?

On average it took 330.54 days on average for the stock forecasts to be realized with a an average price target met ratio 68.48

Which analyst has the current highest performing score on PCRX (Pacira Pharmaceuticals) with a proven track record?

LIANA MOUSSATOS

Which analyst has the most public recommendations on PCRX (Pacira Pharmaceuticals)?

Liana Moussatos works at WEDBUSH and has 5 price targets and 7 ratings on PCRX

Which analyst is the currently most bullish on PCRX (Pacira Pharmaceuticals)?

Liana Moussatos with highest potential upside - $77.4

Which analyst is the currently most reserved on PCRX (Pacira Pharmaceuticals)?

Irina Koffler with lowest potential downside - -$11.69

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?